DONEGAL MUTUAL INSURANCE CO purchased $382K of DGICA

DONEGAL MUTUAL INSURANCE CO purchased 19,595 shares of DONEGAL GROUP INC (DGICA) at an average of $19.48 ($19.43–$19.53, $0.38M total) across 2 trades over 2026-09-02 to 2026-09-03.

Original reporting
SEC EDGAR · DONEGAL MUTUAL INSURANCE CO
Published Sep 4, 2026, 12:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 3:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
high confidence
Mentioned
$DGICA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

The transaction is routine and does not suggest a material change in company fundamentals.

02

Market read

Limited relevance; typical insider stake increase with negligible market impact.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 5/10Novelty 5/10Timing: filing date 2026-09-04

Background

Donegal Group Inc is a publicly traded insurance holding company. The filing is a standard Form 4 disclosure of insider transactions.

Company-level read

Ticker impact

$DGICANeutralHigh confidence
Context

Form 4 shows Donegal Mutual Insurance Co bought 19,595 shares of Donegal Group Inc for $381.8K, increasing its stake to over 14 million shares.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

Purchase size under $1M and represents a routine stake increase for a 10% owner; no immediate trading signal.

Market effects

none

none

none

Counterpoint

Even small insider buys can precede larger moves, but no evidence here.

Key entities

  • Donegal Mutual Insurance Co

    Reporter of the Form 4 transaction.

  • Donegal Group Inc

    Issuer of the shares purchased.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o